MedDataX Logo

Alcohol Use and Relationships - III

NCT ID: NCT01753986

Last Updated: 2012-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that individuals receiving the brief substance use intervention will have better substance use and intimate partner violence outcomes than individuals receiving the general health improvement intervention. All participants receive standard batterer intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intimate Partner Violence Substance Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brief Alcohol Intervention plus Standard Batterer intervention

Brief Alcohol Intervention plus 40 hours of Standard Batterer intervention

Group Type EXPERIMENTAL

Brief Alcohol Intervention plus Standard Batterer Intervention

Intervention Type BEHAVIORAL

Brief Alcohol Intervention plus 40 hours or Standard Batterer Intervention

General Health Improvement plus Standard batterer intervention

General Health Improvement Intervention plus 40 hours of Standard Batterer intervention

Group Type PLACEBO_COMPARATOR

General Health Improvement Intervention plus Standard Batterer Intervention

Intervention Type BEHAVIORAL

General Health Improvement Intervention plus 40 hours of Standard Batterer Intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief Alcohol Intervention plus Standard Batterer Intervention

Brief Alcohol Intervention plus 40 hours or Standard Batterer Intervention

Intervention Type BEHAVIORAL

General Health Improvement Intervention plus Standard Batterer Intervention

General Health Improvement Intervention plus 40 hours of Standard Batterer Intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participation in Batterer Intervention Program in RI
* Hazardous Drinking

Exclusion Criteria

* drinks too much
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Tennessee, Knoxville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Butler Hospital

Providence, Rhode Island, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gregory Stuart, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1210-005

Identifier Type: -

Identifier Source: org_study_id